N-of-1 Trials in Pediatric Oncology: From a Population-Based Approach to Personalized Medicine—A Review

Pediatric oncology is a critical area where the more efficient development of new treatments is urgently needed. The speed of approval of new drugs is still limited by regulatory requirements and a lack of innovative designs appropriate for trials in children. Childhood cancers meet the criteria of...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Michal Kyr, Adam Svobodnik, Radka Stepanova, Renata Hejnova
Format: article
Langue:EN
Publié: MDPI AG 2021
Sujets:
Accès en ligne:https://doaj.org/article/e362beda12c3412aac9b32d23e3902c8
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!